Cogent Biosciences (COGT) Income towards Parent Company: 2017-2020
Historic Income towards Parent Company for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$11.4 million.
- Cogent Biosciences' Income towards Parent Company fell 594.78% to -$11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.1 million, marking a year-over-year decrease of 157.14%. This contributed to the annual value of -$82.1 million for FY2020, which is 157.14% down from last year.
- Latest data reveals that Cogent Biosciences reported Income towards Parent Company of -$11.4 million as of Q4 2020, which was up 80.09% from -$57.2 million recorded in Q3 2020.
- Cogent Biosciences' 5-year Income towards Parent Company high stood at $2.3 million for Q4 2019, and its period low was -$57.2 million during Q3 2020.
- Moreover, its 3-year median value for Income towards Parent Company was -$9.7 million (2018), whereas its average is -$12.4 million.
- Per our database at Business Quant, Cogent Biosciences' Income towards Parent Company spiked by 126.77% in 2019 and then tumbled by 594.78% in 2020.
- Cogent Biosciences' Income towards Parent Company (Quarterly) stood at -$6.8 million in 2017, then decreased by 26.77% to -$8.6 million in 2018, then skyrocketed by 126.77% to $2.3 million in 2019, then slumped by 594.78% to -$11.4 million in 2020.
- Its Income towards Parent Company was -$11.4 million in Q4 2020, compared to -$57.2 million in Q3 2020 and -$7.4 million in Q2 2020.